SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001273511-19-000103
Filing Date
2019-11-08
Accepted
2019-11-08 16:48:54
Documents
7
Period of Report
2019-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K DATED NOVEMBER 8, 2019 f191007phgform8k.htm 8-K 22951
2 exhibit101.htm EX-10.1 67518
3 exhibit102.htm EX-10.2 77687
4 exhibit103.htm EX-10.3 108877
5 exhibit104.htm EX-10.4 108103
6 exhibit105.htm EX-10.5 66800
7 exhibit106.htm EX-10.6 81696
  Complete submission text file 0001273511-19-000103.txt   535021
Mailing Address 2987 BLACKBEAR COURT COQUITLAM A1 V3E3A2
Business Address 2987 BLACKBEAR COURT COQUITLAM A1 V3E3A2 702-803-9404
Pharmagreen Biotech Inc. (Filer) CIK: 0001435181 (see all company filings)

IRS No.: 980491567 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-56090 | Film No.: 191204680
SIC: 4581 Airports, Flying Fields & Airport Terminal Services